Archive - September 2021
Within3 launches new insights management platform
First patient receives low-dose psilocybin in rare headache disorder trial
SMC OKs three new meds in latest decisions
England to offer COVID-19 jabs to 12- to 15-year-olds
Valneva shares fall as UK cancels COVID-19 vaccine order
AbbVie signs gene therapy deal in eye care
Behaviour change theory
Imfinzi, tremelimumab combo boosts survival outcomes for NSCLC patients